Skip to main content

Mungo Appointed to Board of International Papillomavirus Society

October 1, 2024
Chemtai Mungo, MD, MPH, a member of the Institute for Global Health and Infectious Diseases, has been appointed to the Board of the International Papillomavirus Society (IPVS), the leading global authority on HPV (Human Papillomavirus)-related research and advocacy. The IPVS plays a crucial role in advancing scientific understanding, prevention, and...

OB-GYN Researchers Introduce Topical Therapy Advancements at American Society for Colposcopy and Cervical Pathology

May 27, 2024
Chemtai Mungo, MD, MPH, and Lisa Rahangdale, MD, MPH, presented at the American Society for Colposcopy and Cervical Pathology (ASCCP) meeting on May 4, focusing on the latest advancements in topical therapies for cervical precancer treatment in the U.S. and around the world. Dr. Mungo and Dr. Rahangdale, both obstetricians/gynecologists...

UNC Researchers Lead HPV Research and Global Cancer Scientific Session at the EUROGIN International Multidisciplinary HPV Congress in Stockholm 

March 26, 2024
UNC researchers in cervical cancer prevention, members of the Institute for Global Health and Infectious Diseases and Lineberger Comprehensive Cancer Center, filled the agenda at a recent scientific session for the EUROGIN International Multidisciplinary HPV Conference in Stockholm, Sweden.       EUROGIN’s U.S. Chair Jennifer S. Smith, PhD, professor of...

Chemtai Mungo Interviewed During Cervical Cancer Awareness Month

January 31, 2024
During Cervical Cancer Awareness Month, Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases and an assistant professor of obstetrics and gynecology, was interviewed by Cancer Nursing Today, describing the role nurses can play in prevention and treatment. “Nurses interface with patients—women and men—throughout...